These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 19907311)

  • 1. Subclinical phenotypes of asthma.
    Bradding P; Green RH
    Curr Opin Allergy Clin Immunol; 2010 Feb; 10(1):54-9. PubMed ID: 19907311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The reclassification of asthma based on subphenotypes.
    Green RH; Brightling CE; Bradding P
    Curr Opin Allergy Clin Immunol; 2007 Feb; 7(1):43-50. PubMed ID: 17218810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Airway inflammation assessed by invasive and noninvasive means in severe asthma: eosinophilic and noneosinophilic phenotypes.
    Lemière C; Ernst P; Olivenstein R; Yamauchi Y; Govindaraju K; Ludwig MS; Martin JG; Hamid Q
    J Allergy Clin Immunol; 2006 Nov; 118(5):1033-9. PubMed ID: 17088126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-interleukin-5 antibody therapy in asthma and allergies.
    Corren J
    Curr Opin Allergy Clin Immunol; 2011 Dec; 11(6):565-70. PubMed ID: 21971335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-13 in asthma and allergic disease: asthma phenotypes and targeted therapies.
    Ingram JL; Kraft M
    J Allergy Clin Immunol; 2012 Oct; 130(4):829-42; quiz 843-4. PubMed ID: 22951057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokine regulation of mucus production in a model of allergic asthma.
    Cohn L; Whittaker L; Niu N; Homer RJ
    Novartis Found Symp; 2002; 248():201-13; discussion 213-20, 277-82. PubMed ID: 12568496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of dendritic cells and Th2 lymphocytes in asthma: lessons from eosinophilic airway inflammation in the mouse.
    van Rijt LS; Lambrecht BN
    Microsc Res Tech; 2001 May; 53(4):256-72. PubMed ID: 11340671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Eosinophilia and interleukin-5: role in pulmonary atopic processes].
    Druilhe A; Pretolani M
    Med Trop (Mars); 1998; 58(4 Suppl):437-43. PubMed ID: 10410362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apoptotic eosinophils in sputum from asthmatic patients correlate negatively with levels of IL-5 and eotaxin.
    Xu J; Jiang F; Nayeri F; Zetterström O
    Respir Med; 2007 Jul; 101(7):1447-54. PubMed ID: 17379492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammatory response in induced sputum mononuclear cells from patients with acute exacerbation of asthma.
    Hamzaoui A; Brahim MB; Zhioua A; Ayed K; Hamzaoui K
    Mediators Inflamm; 2000; 9(3-4):147-53. PubMed ID: 11132771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of IL-18-induced innate T cell activation to airway inflammation with mucus hypersecretion and airway hyperresponsiveness.
    Ishikawa Y; Yoshimoto T; Nakanishi K
    Int Immunol; 2006 Jun; 18(6):847-55. PubMed ID: 16611648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-10 deficiency prevents IL-5 overproduction and eosinophilic inflammation in a murine model of asthma-like reaction.
    Yang X; Wang S; Fan Y; Han X
    Eur J Immunol; 2000 Feb; 30(2):382-91. PubMed ID: 10671193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and application of induced sputum analysis in childhood asthma.
    Covar RA; Spahn JD; Martin RJ; Silkoff PE; Sundstrom DA; Murphy J; Szefler SJ
    J Allergy Clin Immunol; 2004 Sep; 114(3):575-82. PubMed ID: 15356559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dendritic cells retrovirally overexpressing IL-12 induce strong Th1 responses to inhaled antigen in the lung but fail to revert established Th2 sensitization.
    Kuipers H; Heirman C; Hijdra D; Muskens F; Willart M; van Meirvenne S; Thielemans K; Hoogsteden HC; Lambrecht BN
    J Leukoc Biol; 2004 Nov; 76(5):1028-38. PubMed ID: 15316032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting eosinophils in asthma: current and future state of cytokine- and chemokine-directed monoclonal therapy.
    Walsh GM
    Expert Rev Clin Immunol; 2010 Sep; 6(5):701-4. PubMed ID: 20828276
    [No Abstract]   [Full Text] [Related]  

  • 16. Asthma phenotyping: a necessity for improved therapeutic precision and new targeted therapies.
    Chung KF
    J Intern Med; 2016 Feb; 279(2):192-204. PubMed ID: 26076339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A study to evaluate safety and efficacy of mepolizumab in patients with moderate persistent asthma.
    Flood-Page P; Swenson C; Faiferman I; Matthews J; Williams M; Brannick L; Robinson D; Wenzel S; Busse W; Hansel TT; Barnes NC;
    Am J Respir Crit Care Med; 2007 Dec; 176(11):1062-71. PubMed ID: 17872493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic therapeutic effects of combined adenovirus-mediated interleukin-10 and interleukin-12 gene therapy on airway inflammation in asthmatic mice.
    Hsu CY; Liu HE; Sheu FY; Leu SJ; Chiang BL; Hsiao G; Lee YL
    J Gene Med; 2010 Jan; 12(1):11-21. PubMed ID: 19866481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Relation between clinical severity of bronchial asthma and degree of airway inflammation assessed by the eosinophilic leukocyte count in induced sputum].
    Chlumský J; Pokorná H
    Vnitr Lek; 2001 Sep; 47(9):604-8. PubMed ID: 11715664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting memory Th2 cells for the treatment of allergic asthma.
    Epstein MM
    Pharmacol Ther; 2006 Jan; 109(1-2):107-36. PubMed ID: 16081161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.